m2p-labs
Key Facts
| Invested since | 2006 |
| Based in | Baesweiler |
| Stage | Exit |
About the company
BioLector® | Microbioreactor
m2p-labs in the news
zum Artikel
High-Tech Gründerfonds: Successful sale of portfolio company m2p-labs GmbH to Beckman Coulter Life Sciences
More startups from Life Sciences
With its modular, AI-native hospital information system, Avelios Medical is laying the foundation for the data-driven hospital of the future. Redesigned to meet clinical requirements, the software reduces the burden …
to Avelios Medical
PreComb Therapeutics AG is a privately held Swiss biotech company founded in 2018 by Jens M. Kelm, Peter Steiner and Olivier Mauti with the aim of developing technologies that bring …
to PreComb
Sedivention is developing a medical device for a new therapy of obesity. The Blizzard cryocatheter freezes the nerve branches, that transmit an increased, inadequate feeling of hunger to the brain …
to Sedivention
Optimization of atrial fibrillation therapy via precise, non-thermal pulsed field ablation
to Argá Medtech
Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer …
to Abalos
Intelligent fluids GmbH is designing innovative high performance cleaning fluids for industrial application that are unique in the world. These intelligent fluids® are based on a groundbreaking, patented technology that …
to intelligent fluids
Development of enzymatic biomanufacturing processes for the production of functional ingredients for nutrition and personal care
to Primogene
SciRhom GmbH is a therapeutic antibody company developing first-in-class antibodies against iRhom2, a key modulator of several major pro-inflammatory signaling pathways, including TNF-alpha signaling. Based on a decade of cutting-edge …
to SciRhom
CereGate is developing a Computer-Brain-Interface (“BCI”) platform that is already capable to successfully submit information into the human brain. The revolutionary software platform is clinically validated and allows for enhanced …
to CereGate
Exit
PreOmics develops and provides innovative technologies for customers around the world for mass spectrometry (MS) – based proteomics using cutting-edge technologies to support researchers in their protein analysis needs.
to PreOmics
Exit
The founders of Kumovis GmbH have set themselves the goal of enabling the additive production of plastic implants and are developing innovative 3D printers specifically for medical products. Kumovis focuses …
to Kumovis
Exit
Sierra Sensors is combining state of the art label-free detection with cutting edge microfluidic sample delivery, sensor design, and automation, to supply researchers with high performance analytical biosensors.
to Sierra Sensors